Prevention of atherosclerosis

References

• Frye RL, Higgins MW, Beller GA, et al. Major demographic and epidemiologic trends affecting adult cardiology. J Am Coll Cardiol 1988; 12(3): 840–6
   PubMed Web of Science ®Google Scholar
• Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framing- ham study. Ann Intern Med 1979; 90(1): 85–91
   PubMed Web of Science ®Google Scholar
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984: 251(3): 365–74
   PubMed Web of Science ®Google Scholar
• Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987: 317(20): 1237–45
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low- density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320(14): 915–24
   PubMed Web of Science ®Google Scholar
• Quinn MT, Parthasarathy S, Fong LG, et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Nad Acad Sci USA 1987: 84(9): 2995–8
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis—an update. N Engl J Med 1986: 314(8): 488–500
   PubMed Web of Science ®Google Scholar
• Jialal I, Freeman DA, Grundy SM. Varying susceptibility of different low density lipoproteins to oxidative modification. Arterioscler Thromb 1991: 11(3): 482–8
   PubMed Web of Science ®Google Scholar
• Harats D, Ben-Naim M, Dabach Y, et al. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989; 79(2–3): 245–52
   PubMed Web of Science ®Google Scholar
• Babiy AV, Gebicki JM, Sullivan DR, et al. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacol 1992; 43(5): 995–1000
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044(2): 275–83
   PubMed Web of Science ®Google Scholar
• de Graaf J, Hak-Lemmers HL, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991: 11(2): 298–306
   PubMed Web of Science ®Google Scholar
• Gey KF, Brubacher GB, Stä helin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987: 45(5 Suppl): 1368–77
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssö nen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86(3): 803–11
   PubMed Web of Science ®Google Scholar
• Milani RV, Lavie CJ. Antioxidants in the prevention of cardiovascular disease. In: Messerli FH, ed. Cardiovascular drug therapy. 2d ed. Philadelphia: Saunders (in press)
   Google Scholar
• O'Keefe JH, Lavie CJ, McCallister BD. Insights into the pathogenesis and prevention of coronary artery disease. Mayo Clin Proc 1995; 0: 69–79
   Google Scholar
• Lavie CJ, Milani RV, O'Keefe JA, et al. Potential role of antioxidants for primary and secondary prevention of coronary heart disease in the elderly. Cardiol Elderly 1995; 3: 21–5
   Web of Science ®Google Scholar
• Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993: 328(20): 1444–9
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328(20): l450–6
   Web of Science ®Google Scholar
• Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992: 3(3): 194–202
   PubMed Web of Science ®Google Scholar
• Gaziano JM, Manson JE, Ridker PM, et al. Beta carotene therapy for chronic stable angina. (Abstr) Circulation 1990: 82(Suppl): III-201
   Google Scholar
• Salonen JT, Alfithan G, Huttunen JK, et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982: 2(8291): 175–9
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Alfithan G, Huttunen JK, et al. Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br Med J (Clin Res) 1983; 287(6391): 517–9
   PubMed Web of Science ®Google Scholar
• Ringstad J, Jacobsen BK, Thomassen Y, et al. The Tromso Heart Study: serum selenium and risk ot myocardial infarction: a nested case-control study. J Epidemiol Community Health 1987; 41(4): 329–32
   PubMed Web of Science ®Google Scholar
• Kok FJ, van Poppel G, Meise J, et al. Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis? Atherosclerosis 1991: 31(1): 85–90
   Web of Science ®Google Scholar
• Salonen JT. Selenium in ischaemic heart disease. Int J Epidemiol 1987; 16(Suppl): 323–8
   PubMed Web of Science ®Google Scholar
• O'Keefe JH, Lavie CJ, O'Keefe JO. Dietary prevention ot coronary artery disease: how to help patients modify eating habits and reduce cholesterol. Postgrad Med 1989: 85(6): 243–61
   PubMed Web of Science ®Google Scholar
• Colquhoun DM, Moores D, Somerset SM, et al. Comparison of the effects on lipoproteins and apolipoproteins of a diet high in monounsaturated fatty acids, enriched with avocado, and a high-carbohydrate diet. Am J Clin Nutr 1992; 56(4): 671–7
   PubMed Web of Science ®Google Scholar
• Reaven P, Parthasarathy S, Grasse BJ, et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr 1991; 54(4): 701–6
   PubMed Web of Science ®Google Scholar
• Salen P, de Lorgeril M, Boissonnat P, et al. Effects of a French Mediterranean diet on heart transplant recipients with hypercholesterolemia. Am J Cardiol 1994: 73(11): 825–7
   PubMed Web of Science ®Google Scholar
• Reaven PD, Tribble D. Effects of vitamin E and oleic acid-rich diets on the susceptibility of LDL subtractions to oxidation. (Abstr) Circulation 1993; 88(Nov): 3033
   Web of Science ®Google Scholar
• de Lorgeril M, Mamelle N, Salen P, et al. A Mediterranean-type diet in the secondary prevention of coronary heart disease. (Abstr) Circulation 1993; 88(Nov): I-635
   Web of Science ®Google Scholar
• Schneider JE, Berk BC, Gravanis MB, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injuruy: a possible role for antioxidants in restenosis. Circulation 1993; 88(2): 628–37
   PubMed Web of Science ®Google Scholar
• Walldius G, Regnströ m J, Nilsson J, et al. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1993: 71(6): 15–9B
   Web of Science ®Google Scholar
• Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984: 74(5): 1890–4
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssö nen K, Korpela H, et al. High stored iron levels are associated with excess risk ot myocardial infarction in eastern Finnish men. Circulation 1992; 86(3): 803–11
   PubMed Web of Science ®Google Scholar
• Ascherio A, Willett WC, Rimm EB, et al. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89(3): 969–74
   PubMed Web of Science ®Google Scholar
• Salonen JT, Salonen R, Korpela H, et al. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland. Am J Epidemiol 1991; 134(3): 268–76
   PubMed Web of Science ®Google Scholar
• Kok FJ, Van Duijn CM, Hofinan A, et al. Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Eidemiol 1988; 128(2): 352–9
   PubMed Web of Science ®Google Scholar
• Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994: 330(16): 1119–24
   PubMed Web of Science ®Google Scholar
• Steinberg D. Antioxidant vitamins and coronary heart disease. (Editorial) N Engl J Med 1993: 328(20): 1487–9
   PubMed Web of Science ®Google Scholar
• O'Keefe JH Jr, Lavie CJ. Vitamin E and the risk of coronary disease. (Letter) N Engl J Med 1993; 329(19): 1424
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Genton E. Hemostatis, thrombosis, and antiplatelet therapy: implications for prevention of cardiovascular diseases. Cardiovasc Rev Rep 1991; 12: 24–47
   Google Scholar
• Lavie CJ, Gersh BJ. Acute myocardial infarction: initial manifestations, management, and prognosis. Mayo Clin Proc 1990: 65(4): 531–48
   PubMed Web of Science ®Google Scholar